BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kurte M, Vega-Letter AM, Luz-Crawford P, Djouad F, Noël D, Khoury M, Carrión F. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE. Stem Cell Res Ther 2020;11:416. [PMID: 32988406 DOI: 10.1186/s13287-020-01840-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shevtsova YA, Goryunov KV, Babenko VA, Pevzner IB, Vtorushina VV, Inviyaeva EV, Krechetova LV, Zorova LD, Plotnikov EY, Zorov DB, Sukhikh GT, Silachev DN. Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches. Antioxidants 2022;11:1910. [DOI: 10.3390/antiox11101910] [Reference Citation Analysis]
2 Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol 2022;13:1010399. [DOI: 10.3389/fimmu.2022.1010399] [Reference Citation Analysis]
3 Skibber MA, Olson SD, Prabhakara KS, Gill BS, Cox CS. Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction. Front Immunol 2022;13:874698. [DOI: 10.3389/fimmu.2022.874698] [Reference Citation Analysis]
4 Li YE, Ajoolabady A, Dhanasekaran M, Ren J. Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy. Pharmacol Res 2022;182:106334. [PMID: 35779816 DOI: 10.1016/j.phrs.2022.106334] [Reference Citation Analysis]
5 Creamer DG, Schmiedt CW, Bullington AC, Caster CM, Schmiedt JM, Hurley DJ, Berghaus RD. Influence of exposure to microbial ligands, immunosuppressive drugs and chronic kidney disease on endogenous immunomodulatory gene expression in feline adipose-derived mesenchymal stem cells. J Feline Med Surg 2022;:1098612X221083074. [PMID: 35302413 DOI: 10.1177/1098612X221083074] [Reference Citation Analysis]
6 Velarde F, Ezquerra S, Delbruyere X, Caicedo A, Hidalgo Y, Khoury M. Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact. Cell Mol Life Sci 2022;79:177. [PMID: 35247083 DOI: 10.1007/s00018-022-04207-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Huang Y, Liu Q, Liu L, Huo F, Guo S, Tian W. Lipopolysaccharide-Preconditioned Dental Follicle Stem Cells Derived Small Extracellular Vesicles Treating Periodontitis via Reactive Oxygen Species/Mitogen-Activated Protein Kinase Signaling-Mediated Antioxidant Effect. IJN 2022;Volume 17:799-819. [DOI: 10.2147/ijn.s350869] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li YX, Liu T, Liang YW, Huang JJ, Huang JS, Liu XG, Cheng ZY, Lu SX, Li M, Huang L. Integrative analysis of long non-coding RNA and messenger RNA expression in toll-like receptor 4-primed mesenchymal stem cells of ankylosing spondylitis. Ann Transl Med 2021;9:1563. [PMID: 34790769 DOI: 10.21037/atm-21-5020] [Reference Citation Analysis]
9 Loke XY, Imran SAM, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int J Mol Sci 2021;22:12421. [PMID: 34830303 DOI: 10.3390/ijms222212421] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Alshareef GH, Mohammed AE, Abumaree M, Basmaeil YS. Phenotypic and Functional Responses of Human Decidua Basalis Mesenchymal Stem/Stromal Cells to Lipopolysaccharide of Gram-Negative Bacteria. Stem Cells Cloning 2021;14:51-69. [PMID: 34754198 DOI: 10.2147/SCCAA.S332952] [Reference Citation Analysis]
11 Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate. Stem Cell Res Ther 2021;12:564. [PMID: 34732259 DOI: 10.1186/s13287-021-02622-0] [Reference Citation Analysis]
12 Dunbar H, Weiss DJ, Rolandsson Enes S, Laffey JG, English K. The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing. Cells 2021;10:2982. [PMID: 34831203 DOI: 10.3390/cells10112982] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Masalova OV, Lesnova EI, Klimova RR, Ivanov AV, Kushch AA. Mesenchymal Stem Cells Can Both Enhance and Inhibit the Cellular Response to DNA Immunization by Genes of Nonstructural Proteins of the Hepatitis C Virus. Int J Mol Sci 2021;22:8121. [PMID: 34360889 DOI: 10.3390/ijms22158121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Becerra J, Duran I. Inflammation, a common mechanism in frailty and COVID19, and stem cells as a therapeutic approach. Stem Cells Transl Med 2021. [PMID: 34164948 DOI: 10.1002/sctm.21-0074] [Reference Citation Analysis]
15 Banavar SR, Rawal SY, Pulikkotil SJ, Daood U, Paterson IC, Davamani FA, Kajiya M, Kurihara H, Khoo SP, Tan EL. 3D Clumps/Extracellular Matrix Complexes of Periodontal Ligament Stem Cells Ameliorate the Attenuating Effects of LPS on Proliferation and Osteogenic Potential. J Pers Med 2021;11:528. [PMID: 34207600 DOI: 10.3390/jpm11060528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Figueroa-Valdés AI, de la Fuente C, Hidalgo Y, Vega-Letter AM, Tapia-Limonchi R, Khoury M, Alcayaga-Miranda F. A Chemically Defined, Xeno- and Blood-Free Culture Medium Sustains Increased Production of Small Extracellular Vesicles From Mesenchymal Stem Cells. Front Bioeng Biotechnol 2021;9:619930. [PMID: 34124014 DOI: 10.3389/fbioe.2021.619930] [Reference Citation Analysis]
17 Seo Y, Kang MJ, Kim HS. Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases. Int J Mol Sci 2021;22:3397. [PMID: 33806241 DOI: 10.3390/ijms22073397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]